The number of people with susceptibility test result for rifampicin in United Kingdom

United Kingdom: The number of people with susceptibility test result for rifampicin was 1,734 in 2021. ▼ Falling

Latest (2021)
1,734
Change on year
up 12.2%
World rank
54th
of 155 countries
All-time high
2,011
in 2017
All-time low
1,546
in 2020
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in United Kingdom, 2017–2021

05001.0k1.5k2.0k2017201920212017: 2.0k2018: 1.9k2019: 1.9k2020: 1.5k2021: 1.7k

Source: World Health Organization, Global Health Observatory.

Analysis

United Kingdom recorded 1,734 for the number of people with susceptibility test result for rifampicin in 2021.

That represents a change of up 12.2% on the previous year and down 13.8% over five years.

United Kingdom ranks 54th of 155 countries on this measure, in the middle of the range.

The number of people with susceptibility test result for rifampicin in United Kingdom, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in United Kingdom, 2017 to 2021.
Year Value Change
2017 2,011
2018 1,925 -4.3%
2019 1,906 -1.0%
2020 1,546 -18.9%
2021 1,734 +12.2%

United Kingdom compared with similar countries

  • United Kingdom's 1,734 is above the median for high income countries, which is 142, 12.2× the median. (61 countries reporting)
  • United Kingdom's 1,734 is above the median for Europe & Central Asia, which is 229.5, 7.6× the median. (44 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 1,947 1,906 2,011 3
2020s 1,640 1,546 1,734 2

Countries ranked near United Kingdom

  1. 51 Iran 1,828 compare
  2. 52 Togo 1,805 compare
  3. 53 Chile 1,772 compare
  4. 55 Dominican Republic 1,724 compare
  5. 56 Paraguay 1,639 compare
  6. 57 Liberia 1,486 compare

See the full ranking of 157 places →

More health data for United Kingdom

All data for United Kingdom →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in United Kingdom?
The number of people with susceptibility test result for rifampicin in United Kingdom was 1,734 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in United Kingdom?
The highest recorded value was 2,011 in 2017.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in United Kingdom?
The lowest recorded value was 1,546 in 2020.
How does United Kingdom rank for the number of people with susceptibility test result for rifampicin?
United Kingdom ranks 54th out of 155 countries with data for 2021.
Where does this United Kingdom data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in United Kingdom. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/united-kingdom/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/united-kingdom/">The number of people with susceptibility test result for rifampicin in United Kingdom</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed